| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | INSULET CORPORATION | 198,000 | 5,130,000 | 0.09% | ||
| 52 | TAIWAN SEMICONDUCTOR MFG LTD | 238,160 | 4,942,000 | 0.08% | ||
| 53 | CERNER CORP | 80,678 | 4,838,000 | 0.08% | ||
| 54 | CARA THERAPEUTICS INC | 338,081 | 4,831,000 | 0.08% | ||
| 55 | TETRAPHASE PHARMACEUTICALS INC COM | 625,510 | 4,666,000 | 0.08% | ||
| 56 | DYNAVAX TECHNOLOGIES CORP | 187,522 | 4,602,000 | 0.08% | ||
| 57 | EXACT SCIENCES CORP | 250,000 | 4,498,000 | 0.08% | ||
| 58 | NUVASIVE INC | 93,160 | 4,492,000 | 0.08% | ||
| 59 | DEXCOM INC | 49,925 | 4,287,000 | 0.07% | ||
| 60 | SUPERNUS PHARMACEUTICALS INC | 290,000 | 4,069,000 | 0.07% | ||
| 61 | LDR HLDG CORP COM | 116,917 | 4,037,000 | 0.07% | ||
| 62 | MEDIVATION INC | 92,262 | 3,921,000 | 0.07% | ||
| 63 | ULTRAGENYX PHARMACEUTICAL INC COM | 40,000 | 3,852,000 | 0.06% | ||
| 64 | RELYPSA INC | 200,360 | 3,709,000 | 0.06% | ||
| 65 | IONIS PHARMACEUTICAL | 91,060 | 3,681,000 | 0.06% | ||
| 66 | MIMEDX GROUP INC COM | 380,000 | 3,667,000 | 0.06% | ||
| 67 | NOVADAQ TECHNOLOGIES INC | 350,000 | 3,650,000 | 0.06% | ||
| 68 | AERIE PHARMACEUTICALS INC COM | 201,350 | 3,572,000 | 0.06% | ||
| 69 | ACADIA COMPANY COM | 50,000 | 3,314,000 | 0.06% | ||
| 70 | PORTOLA PHARMACEUTICALS INC | 77,013 | 3,282,000 | 0.06% | ||
| 71 | SPECTRANETICS CORP | 273,956 | 3,230,000 | 0.05% | ||
| 72 | SPARK THERAPEUTICS INCORPORATED | 77,220 | 3,222,000 | 0.05% | ||
| 73 | KEMPHARM INC | 165,000 | 3,198,000 | 0.05% | ||
| 74 | K2M GROUP HLDGS INC COM | 171,151 | 3,183,000 | 0.05% | ||
| 75 | ATHENA HEALTH INC. | 23,222 | 3,097,000 | 0.05% | ||
| 76 | Innocoll | 245,184 | 3,070,000 | 0.05% | ||
| 77 | HUMANA INC | 14,800 | 2,649,000 | 0.04% | ||
| 78 | KITE PHARMA INCORPORATED | 47,000 | 2,617,000 | 0.04% | ||
| 79 | COHERUS BIOSCIENCES INC COM | 124,000 | 2,485,000 | 0.04% | ||
| 80 | BOSTON SCIENTIFIC CORP | 150,000 | 2,462,000 | 0.04% | ||
| 81 | ENDO INTL PLC | 35,000 | 2,425,000 | 0.04% | ||
| 82 | VERTEX PHARMACEUTICALS INC | 23,100 | 2,406,000 | 0.04% | ||
| 83 | ZELTIQ AESTHETICS INC | 75,000 | 2,402,000 | 0.04% | ||
| 84 | EXAMWORKS GROUP INC COM | 75,000 | 2,193,000 | 0.04% | ||
| 85 | REGULUS THERAPEUTICS INC COM | 300,000 | 1,962,000 | 0.03% | ||
| 86 | SORRENTO THERAPEUTICS INC COM NEW | 222,981 | 1,871,000 | 0.03% | ||
| 87 | TROVAGENE INC | 328,584 | 1,870,000 | 0.03% | ||
| 88 | MASTERCARD INCORPORATED | 20,000 | 1,802,000 | 0.03% | ||
| 89 | DANAHER CORP DEL | 20,570 | 1,753,000 | 0.03% | ||
| 90 | EDISON INTL | 26,900 | 1,696,000 | 0.03% | ||
| 91 | Oxford Immunotec Global PLC | 120,460 | 1,626,000 | 0.03% | ||
| 92 | REGENERON PHARMACEUTICALS | 3,420 | 1,591,000 | 0.03% | ||
| 93 | REPROS THERAPEUTICS INC | 200,000 | 1,486,000 | 0.02% | ||
| 94 | TORONTO DOMINION BK ONT | 28,220 | 1,485,000 | 0.02% | ||
| 95 | KERYX BIOPHARMACEUTICALS INCORPORATED | 421,110 | 1,482,000 | 0.02% | ||
| 96 | TRANSENTERIX INC | 637,169 | 1,440,000 | 0.02% | ||
| 97 | JPMORGAN CHASE & CO | 22,500 | 1,372,000 | 0.02% | ||
| 98 | MEDNAX INC | 17,000 | 1,305,000 | 0.02% | ||
| 99 | RADIUS HEALTH INCORPORATED COM NEW | 18,330 | 1,270,000 | 0.02% | ||
| 100 | MEDTRONIC PLC | 17,800 | 1,192,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001625244-15-000007, filed 2015.11.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
